Table 1.
Patient characteristics
| No. | Sex | Age (yr) | Location | Size (mm) | Metastases | UICC stage | Vaccine (times) | OS (d) | PFS (d) |
HLA type |
Best overall tumor response | |||||
| HLA-A | DRB1 | DPB1 | ||||||||||||||
| 1 | M | 70 | Body | 22 | Peritonitis | IV | 35 | 582 | 440 | 02:01 | 24:02 | 04:05 | 15:02 | 05:01 | 09:01 | Stable disease |
| 2 | M | 68 | Body | 15 | Liver, lymph nodes | IV | 46 | 717 | 208 | 24:02 | 33:03 | 08:03 | 13:02 | 02:02 | 04:01 | Stable disease |
| 3 | F | 49 | Head | 18 | Liver, peritonitis, lymph nodes | IV | 7 | 133 | 26 | 02:01 | 24:02 | 04:05 | 09:01 | 02:02 | 05:01 | Progressive disease |
| 4 | M | 35 | Body | 25 | Liver, lymph nodes | IV | 6 | 283 | 147 | 02:01 | - | 09:01 | 15:01 | 02:01 | 05:01 | Stable disease |
| 5 | F | 72 | Body | 22 | Peritonitis, lymph nodes | IV | 14 | 215 | 109 | 02:06 | 24:02 | 08:02 | 12:01 | 02:01 | 05:01 | Stable disease |
| 6 | F | 69 | Body-tail | 45 | Lymph nodes | IV | 71+ | 1050+ | 545 | 24:02 | 33:03 | 13:02 | 15:01 | 04:01 | 13:01 | Stable disease |
| 7 | M | 39 | Head-body | 30 | Peritonitis | IV | 20 | 325 | 290 | 02:10 | 24:02 | 15:01 | 15:02 | 02:02 | 09:01 | Stable disease |
Stable disease conformation is determined at least for more than 2 mo. Ope: Operation; Cx: Chemotherapy; OS: Overall survival; PFS: Progression-free survival; HLA: Human leukocyte antigen.